| Primary |
| Attention Deficit/hyperactivity Disorder |
53.0% |
| Depression |
7.8% |
| Psychomotor Hyperactivity |
6.0% |
| Bipolar Disorder |
4.1% |
| Off Label Use |
4.1% |
| Disturbance In Attention |
3.7% |
| Anxiety |
2.8% |
| Narcolepsy |
2.8% |
| Epilepsy |
2.3% |
| Sleep Disorder |
2.3% |
| Asthma |
1.4% |
| Headache |
1.4% |
| Impulsive Behaviour |
1.4% |
| Memory Impairment |
1.4% |
| Antidepressant Therapy |
0.9% |
| Convulsion |
0.9% |
| Fatigue |
0.9% |
| Hypersensitivity |
0.9% |
| Hypothyroidism |
0.9% |
| Insomnia |
0.9% |
|
| Weight Decreased |
9.7% |
| Wrong Technique In Drug Usage Process |
8.3% |
| Psychomotor Hyperactivity |
6.9% |
| Tremor |
6.9% |
| Vomiting |
6.9% |
| Disturbance In Attention |
5.6% |
| Nervousness |
5.6% |
| Somnolence |
5.6% |
| Withdrawal Syndrome |
5.6% |
| Drug Dependence |
4.2% |
| Memory Impairment |
4.2% |
| No Adverse Event |
4.2% |
| Performance Status Decreased |
4.2% |
| Restlessness |
4.2% |
| Weight Increased |
4.2% |
| Depression |
2.8% |
| Drug Intolerance |
2.8% |
| Insomnia |
2.8% |
| Irritability |
2.8% |
| Movement Disorder |
2.8% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
45.1% |
| Psychomotor Hyperactivity |
8.4% |
| Bipolar Disorder |
7.6% |
| Depression |
7.6% |
| Off Label Use |
5.9% |
| Disturbance In Attention |
4.6% |
| Impulsive Behaviour |
3.4% |
| Narcolepsy |
3.0% |
| Anxiety |
1.7% |
| Headache |
1.7% |
| Osteoporosis |
1.7% |
| Abdominal Discomfort |
1.3% |
| Antidepressant Therapy |
1.3% |
| Anxiolytic Therapy |
1.3% |
| Memory Impairment |
1.3% |
| Asthenia |
0.8% |
| Asthma |
0.8% |
| Autism |
0.8% |
| Convulsion |
0.8% |
| Dependence |
0.8% |
|
| Memory Impairment |
17.8% |
| Vomiting |
8.9% |
| Weight Decreased |
8.9% |
| Wrong Technique In Drug Usage Process |
7.8% |
| Tremor |
6.7% |
| Withdrawal Syndrome |
6.7% |
| Nervousness |
5.6% |
| Pharyngeal Oedema |
5.6% |
| Nausea |
4.4% |
| Disturbance In Attention |
3.3% |
| No Adverse Event |
3.3% |
| Somnolence |
3.3% |
| Pain |
2.2% |
| Psychomotor Hyperactivity |
2.2% |
| Rebound Effect |
2.2% |
| Sepsis |
2.2% |
| Swelling |
2.2% |
| Tachycardia |
2.2% |
| Tongue Dry |
2.2% |
| Toxicity To Various Agents |
2.2% |
|
| Concomitant |
| Attention Deficit/hyperactivity Disorder |
21.4% |
| Product Used For Unknown Indication |
21.4% |
| Antidepressant Therapy |
14.3% |
| Pain |
14.3% |
| Crohn's Disease |
7.1% |
| Fibromyalgia |
7.1% |
| Relapsing-remitting Multiple Sclerosis |
7.1% |
| Relaxation Therapy |
7.1% |
|
| Crohn's Disease |
33.3% |
| Postoperative Wound Infection |
33.3% |
| Vomiting |
33.3% |
|
| Interacting |
| Anxiety |
33.3% |
| Attention Deficit/hyperactivity Disorder |
33.3% |
| Depression |
33.3% |
|
| Norepinephrine Increased |
100.0% |
|
